@Article{cmes.2025.070419,
AUTHOR = {Ngoc-Hoang-Quyen Nguyen, Thanh-Tung Nguyen, Anh-Cang Phan},
TITLE = {A Lightweight Explainable Deep Learning for Blood Cell Classification},
JOURNAL = {Computer Modeling in Engineering \& Sciences},
VOLUME = {145},
YEAR = {2025},
NUMBER = {2},
PAGES = {2435--2456},
URL = {http://www.techscience.com/CMES/v145n2/64555},
ISSN = {1526-1506},
ABSTRACT = {Blood cell disorders are among the leading causes of serious diseases such as leukemia, anemia, blood clotting disorders, and immune-related conditions. The global incidence of hematological diseases is increasing, affecting both children and adults. In clinical practice, blood smear analysis is still largely performed manually, relying heavily on the experience and expertise of laboratory technicians or hematologists. This manual process introduces risks of diagnostic errors, especially in cases with rare or morphologically ambiguous cells. The situation is more critical in developing countries, where there is a shortage of specialized medical personnel and limited access to modern diagnostic tools. High testing costs and delays in diagnosis hinder access to quality healthcare services. In this context, the integration of Artificial Intelligence (AI), particularly Explainable AI (XAI) based on deep learning, offers a promising solution for improving the accuracy, efficiency, and transparency of hematological diagnostics. In this study, we propose a Ghost Residual Network (GRsNet) integrated with XAI techniques such as Gradient-weighted Class Activation Mapping (Grad-CAM), Local Interpretable Model-Agnostic Explanations (LIME), and SHapley Additive exPlanations (SHAP) for automatic blood cell classification. These techniques provide visual explanations by highlighting important regions in the input images, thereby supporting clinical decision-making. The proposed model is evaluated on two public datasets: Naturalize 2K-PBC and Microscopic Blood Cell, achieving a classification accuracy of up to 95%. The results demonstrate the model’s strong potential for automated hematological diagnosis, particularly in resource-constrained settings. It not only enhances diagnostic reliability but also contributes to advancing digital transformation and equitable access to AI-driven healthcare in developing regions.},
DOI = {10.32604/cmes.2025.070419}
}